News|Videos|June 27, 2024

Conversations With Patients About Mild/Moderate Multiple Sclerosis

The expert panel examines early multiple sclerosis (MS) and patients with mild MS even in later stages of the disease, emphasizing crucial information to convey to patients throughout their journey; faculty also explore cases where disease-modifying therapies (DMTs) may not be utilized.

  1. What is important for physicians to share with different types of patients and with patients at different junctures of their MS journey?
  2. Are there any patients with mild disease who won’t be treated with DMTs?

Newsletter

Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.

Latest CME